Weinschenk, Toni,Fritsche, Jens,Schoor, Oliver,Singh, Harpreet,Mahr, Andrea
申请号：
NZ74743816
公开号：
NZ747438A
申请日:
2016.08.26
申请国别(地区):
NZ
年份:
2020
代理人:
摘要：
The present invention relates to peptides, nucleic acids and cells for use in immunotherapy of cancers. In particular, the present invention relates to uses of peptides comprising the amino acid sequence of SEQ ID No. 323, or variant sequences thereof that is at least 88% homologous to SEQ ID No. 323, and wherein said variant binds to molecule(s) of the major histocompatibility complex (MHC) and/or induces T cells cross-reacting with said variant； or a pharmaceutical acceptable salt of said variant, wherein said peptide is not a full-length polypeptide. The invention further relates to nucleic acids encoding the same or cells expressing the same.
